Initial surveillance of 2009 influenza a (H1N1) pandemic in the European Union and European economic area

Eurosurveillance

Volumn 15, Issue 49, 2010, Pages 2-

  Devaux, I ^a   Kreidl, P ^a   Penttinen, P ^a   Salminen, Mika ^a   Zucs, P ^a   Ammon, A ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

2009 H1N1 INFLUENZA; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; EUROPE; EUROPEAN UNION; FEMALE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PNEUMONIA; PUBLIC HEALTH; RESPIRATORY TRACT INFECTION; SEX RATIO; SOCIAL STATUS; SYMPTOMATOLOGY; TRAVEL;

EID: 78650620553     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. World Health Organization (WHO). International health regulations (2005) -- 2nd ed. II. Title: IHR (2005). Geneva: WHO; 2008. Available from: http://whqlibdoc.who.int/publications/2008/9789241580410_eng.pdf
2. The Early Warning and Response System for communicable diseases in the EU: an overview from 1999 to 2005. Euro Surveill. 2006;11(12):pii=666. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=666
3. European Centre for Disease Prevention and Control (ECDC). Stockholm: ECDC; 2009-2010. Daily situation reports on influenza A(H1N1). http://www.ecdc.europa.eu/en/healthtopics/Pages/Influenza_A(H1N1)_Outbreak.aspx
4. European Commission. Commission Decision of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. OJ L 110/58 1.5.2009. Available from: http://eurlex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:110:0058:0059:EN:PDF
5. European Centre for Disease Prevention and Control (ECDC). Stockholm: ECDC; 2009-2010. Analysis of influenza A(H1N1) v individual case reports in EU and EEA countries. Available from: www.ecdc.europa.eu/en/healthtopics/H1N1/whats_new/Pages/weekly_surveillance_reports.aspx
6. ECDC working group on influenza A(H1N1)v. Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries. Euro Surveill. 2009;14(23):pii=19238. Stockholm: ECDC; 2009. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19238
7. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, HPA Northern Ireland Swine influenza investigation teams. Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April - June 2009. Euro Surveill. 2009;14(22):pii=19232. Available from: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19232
8. Novel influenza A(H1N1) investigation team. Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. Euro Surveill. 2009;14(31):pii=19295. Available from: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19295
9. Surveillance Group for New Influenza A(H1N1) Virus Investigation and Control in Spain. New influenza A(H1N1) virus infections in Spain, April-May 2009. Euro Surveill.2009;14(19):pii=19209. Available from: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19209
10. Influenza A(H1N1)v investigation teams. Modified surveillance of influenza A(H1N1)v virus infections in France. Euro Surveill. 2009;14(29):pii=19276. Available from: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19276
11. Surveillance Group for New Influenza A(H1N1) Virus Investigation in Italy. Virological surveillance of human cases of influenza A(H1N1)v virus in Italy: preliminary results. Euro Surveill. 2009;14(24):pii=19247. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19247
12. Belgian working group on influenza A(H1N1)v. Influenza A(H1N1)v virus infections in Belgium, May-June 2009. Euro Surveill. 2009;14(28):pii=19270. Available from: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19270
13. Hahné S, Donker T, Meijer A, Timen A, van Steenbergen J, Osterhaus A, et al. Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Euro Surveill. 2009;14(27):pii=19267. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19267
14. Lytras T, Theocharopoulos G, Tsiodras S, Mentis A, Panagiotopoulos T, Bonovas S, et al. Enhanced surveillance of nfluenza A(H1N1)v in Greece during the containment phase. Euro Surveill. 2009;14(29):pii=19275. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19275
15. Health Protection Agency (HPA). Pandemic H1N1 2009 in England: an overview of initial epidemiological findings and implications for the second wave. Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1258560552857
16. Eurostat. [Internet]. Total population of European Union and European Economic Area countries on 1 January. Available from: http://epp.eurostat.ec.europa.eu/tgm/table.do?tab=table&language=en&pcode=tps00001&tableSelection=1&footnotes=yes&labeling=labels&plugin=1
17. World Health Organization (WHO). Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance, 10 July 2009. Available from: http://www.who.int/csr/disease/swineflu/guidance/surveillance/WHO_case_definition_swine_flu_2009_04_29.pdf
18. European Centre for Disease Prevention and Control (ECDC). The 2009 A(H1N1) pandemic in Europe. Stockholm: ECDC; 2010. http://ecdc.europa.eu/en/publications/Publications/101108_SPR_pandemic_experience.pdf
19. van't Klooster TM, Wielders CC, Donker T, Isken L, Meijer A, van den Wijngaard CC, et al. Surveillance of Hospitalisations for 2009 Pandemic Influenza A(H1N1) in the Netherlands, 5 June - 31 December 2009. Euro Surveill. 2010;15(2):pii=19461. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19461
20. Writing committee of the WHO consultation. Clinical aspects of pandemic 2009 influenza.N Engl J Med. 362(18):1708-1719.
21. Aho M, Lyytikaïnen O, Nyholm JE, Kuitunen T, Rönkkö E, Santanen R, Ziegler T, Nikkari S. Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison - a serological survey. Euro Surveill. 2010;15(45):pii=19709. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19709
22. World health Organization (WHO). Seroepidemiological studies of pandemic influenza A(H1N1) 2009 virus. Wkly Epidemiol Rec. 2010;85(24):229-35
23. World Health Organization (WHO). Epidemiology summary of pandemic influenza a(H1N1) 2009 virus - Ontario, Canada, June 2009. Weekly epidemiological record. 2009;84(47), 485-492. Available from: http://www.who.int/wer/2009/wer8447.pdf
24. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. 2009 Pandemic Influenza A (H1N1) Virus ospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935-1944.
25. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302(17):1896-902.
26. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al.; Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009 Nov 4;302(17):1872-1879. Epub 2009 Oct 12.
27. ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925-1934.
28. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA. 2009;302(17):1880-1887.
29. Centers for Disese Control and Prevention (CDC). Serum crossreactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep. 2009;58(19);521-524.
30. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010;375(9720):1100-8.
31. Ikonen N, Strengell M, Kinnunen L, Österlund P, Pirhonen J, Broman M, et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 2010;15(5):pii=19478. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19478